Core Viewpoint - The announcement details the lifting of the freeze on certain bank accounts of Chongqing Taiji Industrial (Group) Co., Ltd. and its subsidiary Southwest Pharmaceutical Co., Ltd., which had been frozen due to a drug sales contract dispute. The recovery of these accounts is expected to facilitate normal business operations and financial management [1][2]. Group 1 - The total amount frozen was 62,921,183.15 yuan, with 20 million yuan related to a dispute with Hangzhou Yueming Pharmaceutical Technology Co., Ltd. and 42,921,183.15 yuan related to a dispute with Tibet Huiye Pharmaceutical Technology Co., Ltd. [1] - As of the disclosure date, the funds related to the dispute with Tibet Huiye Pharmaceutical Technology Co., Ltd. have been fully released, allowing the bank accounts to resume normal operations [1][2]. - The freezing of the bank accounts did not have a significant impact on the company's main operations during the period they were frozen [2].